Analyze Diet

Topic:Drug

The topic of drugs and horses encompasses the study of various pharmacological agents used in equine medicine for therapeutic purposes. This includes the administration of medications for pain management, disease treatment, and performance enhancement. The pharmacokinetics and pharmacodynamics of drugs in horses are key areas of research, as they determine the absorption, distribution, metabolism, and excretion of these substances. Additionally, the topic covers the detection and regulation of substances in competitive equestrian sports to ensure fair play and animal welfare. This page compiles peer-reviewed research studies and scholarly articles that explore the effects, safety, and regulatory aspects of drug use in equine health and performance.
Clotrimazole, ketoconazole, and clodinafop-propargyl as potent growth inhibitors of equine Babesia parasites during in vitro culture.
The Journal of parasitology    July 26, 2003   Volume 89, Issue 3 604-606 doi: 10.1645/0022-3395(2003)089[0604:CKACAP]2.0.CO;2
Bork S, Yokoyama N, Matsuo T, Claveria FG, Fujisaki K, Igarashi I.The antifungal agents clotrimazole (CLT) and ketoconazole (KC) and the herbicide clodinafop-propargyl (CP) inhibit growth of Plasmodium sp., Toxoplasma sp., and Trypanosoma sp. In the present study, we evaluated these drugs against the in vitro growth of the equine protozoan parasites Babesia equi and B. caballi. Clotrimazole (IC50: 2 and 17 microM), KC (IC50: 6 and 22 microM), and CP (IC50: 450 and 354 microM) were effective growth inhibitors. Interestingly, intraerythrocytic KC-treated Babesia sp. were observed to be in immediate contact with the plasma fraction of the blood in electron micr...
Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses.
Equine veterinary journal    July 24, 2003   Volume 35, Issue 5 484-490 doi: 10.2746/042516403775600415
Maxwell LK, Thomasy SM, Slovis N, Kollias-Baker C.Although fentanyl has been reported to cause CNS excitation in horses, a transdermal therapeutic system (TTS) containing this mu agonist has recently been used empirically in equine medicine to treat moderate to severe pain. A better understanding of the disposition of fentanyl following transdermal administration would facilitate the clinical use of TTS fentanyl to obtain analgesia in horses. Objective: To determine the pharmacokinetics of fentanyl following i.v. and TTS patch administration in healthy, mature horses and to evaluate the tolerance of horses to TTS fentanyl administration. Meth...
Comparison of unfractioned and low molecular weight heparin for prophylaxis of coagulopathies in 52 horses with colic: a randomised double-blind clinical trial.
Equine veterinary journal    July 24, 2003   Volume 35, Issue 5 506-513 doi: 10.2746/042516403775600514
Feige K, Schwarzwald CC, Bombeli T.Unfractioned heparin (UFH) is widely used for prophylaxis of coagulation disorders, especially in colic-affected horses. However, it is accompanied by certain side effects. Objective: To compare the efficacy and side effects of unfractioned and low molecular weight heparin (LMWH) in horses with colic. Methods: The study was carried out as a randomised, double-blind, controlled clinical trial. Fifty-two horses with colic were treated subcutaneously with either UFH (heparin calcium, 150 iu/kg bwt initially, followed by 125 iu/kg bwt q. 12 h for 3 days and then 100 iu/kg bwt q. 12 h) or LMWH (dal...
Effects of dosage titration of methylprednisolone acetate and triamcinolone acetonide on interleukin-1-conditioned equine articular cartilage explants in vitro.
Equine veterinary journal    July 24, 2003   Volume 35, Issue 5 444-450 doi: 10.2746/042516403775600479
Dechant JE, Baxter GM, Frisbie DD, Trotter GW, McIlwraith CW.Osteoarthritis is a frequent sequela of joint disease, especially with severe injuries or if attempts at therapy are unsuccessful. Negative and positive effects of corticosteroid treatment of articular cartilage have been demonstrated by in vitro and in vivo studies. Objective: To assess the metabolic effects of varying dosages of methylprednisolone acetate (MPA) and triamcinolone acetonide (TA) on interleukin-1alpha (IL-1) conditioned equine cartilage explants. Our hypothesis was that lower dosages of corticosteroids would be less detrimental to cartilage metabolism than higher dosages. TA wo...
Management of drug-resistant cyathostominosis on a breeding farm in central North Carolina.
Equine veterinary journal    May 21, 2003   Volume 35, Issue 3 246-251 doi: 10.2746/042516403776148264
Little D, Flowers JR, Hammerberg BH, Gardner SY.Possible anthelmintic resistance on a breeding farm where a rapid rotation anthelmintic programme had been implemented for 9 years was investigated. Cyathostomins resistant to fenbendazole and pyrantel were documented by faecal worm egg count reduction test (FWECRT). Objective: To 1) manage small strongyle transmission in a herd of horses in which resistance to both pyrantel pamoate and fenbendazole was identified and thereby reduce the risk of clinical disease in the individual animal, 2) monitor the change in resistance patterns over time and 3) monitor the efficacy of ivermectin over the st...
Influence of detomidine and buprenorphine on motor-evoked potentials in horses.
The Veterinary record    May 13, 2003   Volume 152, Issue 17 534-537 doi: 10.1136/vr.152.17.534
Nollet H, Van Ham L, Gasthuys F, Dewulf J, Vanderstraeten G, Deprez P.Horses need to be sedated before they are investigated by transcranial magnetic stimulation because of the mild discomfort induced by the evoked muscle contraction and the noise of stimulation. This paper describes the influence of a combination of detomidine (10 microg/kg bodyweight) and a low dose of buprenorphine (2.4 microg/kg) on the onset latency and peak-to-peak amplitude of magnetic motor-evoked potentials in normal horses. There were no significant differences between measurements of these parameters made before the horses were sedated and measurements made 10 and 30 minutes after the...
Growth inhibitory effect of triclosan on equine and bovine Babesia parasites.
The American journal of tropical medicine and hygiene    April 11, 2003   Volume 68, Issue 3 334-340 
Bork S, Yokoyama N, Matsuo T, Claveria FG, Fujisaki K, Igarashi I.We evaluated the growth inhibitory effect of triclosan, which has recently been reported to inhibit the growth of Plasmodium species and Toxoplasma gondii, on bovine and equine Babesia parasites in in vitro cultures The growth of Babesia bovis and B. bigemina was significantly inhibited in the presence of 100 microg/ml of triclosan, while B. caballi and B. equi were susceptible to as low as 50 microg/ml. Babesia bigemina and B. caballi were completely cleared as early as on the first and second day of the treatment, respectively. These parasites did not exhibit any growth in the subsequent fiv...
Inhibition of six copper-containing amine oxidases by the antidepressant drug tranylcypromine.
Biochimica et biophysica acta    April 11, 2003   Volume 1647, Issue 1-2 252-259 doi: 10.1016/s1570-9639(03)00062-1
Shepard EM, Heggem H, Juda GA, Dooley DM.Potential inhibitory effects of the clinically utilized monoamine oxidase inhibitor tranylcypromine (TCP) on mammalian, plant, bacterial, and fungal copper-containing amine oxidases have been examined. The following enzymes have been investigated: human kidney diamine oxidase (HKAO), bovine plasma amine oxidase (BPAO), equine plasma amine oxidase (EPAO), pea seedling amine oxidase (PSAO), Arthrobacter globiformis amine oxidase (AGAO), and Pichia pastoris lysyl oxidase (PPLO). Only BPAO, EPAO, and AGAO were found to lose significant levels of activity when incubated with varying amounts of TCP....
Pharmacokinetics and pharmacodynamics of clemastine in healthy horses.
Journal of veterinary pharmacology and therapeutics    April 2, 2003   Volume 26, Issue 2 151-157 doi: 10.1046/j.1365-2885.2003.00460.x
Törneke K, Ingvast-Larsson C, Pettersson K, Bergvall K, Hedeland M, Bondesson U, Broström H.Clemastine is an H1 antagonist used in certain allergic disorders in humans and tentatively also in horses, although the pharmacology of the drug in this species has not yet been investigated. In the present study we determined basic pharmacokinetic parameters and compared the effect of the drug measured as inhibition of histamine-induced cutaneous wheal formation in six horses. The most prominent feature of drug disposition after intravenous dose of 50 microg/kg bw was a very rapid initial decline in plasma concentration, followed by a terminal phase with a half-life of 5.4 h. The volume of d...
Expression of the ether-a-go-go (ERG) potassium channel in smooth muscle of the equine gastrointestinal tract and influence on activity of jejunal smooth muscle.
American journal of veterinary research    March 29, 2003   Volume 64, Issue 3 267-272 doi: 10.2460/ajvr.2003.64.267
Lillich JD, Rakestraw PC, Roussel AJ, Finley MR, Ganta S, Freeman LC.To determine whether ether-a-go-go (ERG) potassium channels are expressed in equine gastrointestinal smooth muscle, whether ERG channel antagonists affect jejunal muscle contraction in vitro, and whether plasma cisapride concentrations in horses administered treatment for postoperative ileus (POI) are consistent with ERG channels as drug targets. Methods: Samples of intestinal smooth muscle obtained from 8 horses free of gastrointestinal tract disease and plasma samples obtained from 3 horses administered cisapride for treatment of POI. Methods: Membranes were prepared from the seromuscular la...
Detection and disposition of tolmetin in the horse.
Journal of pharmaceutical and biomedical analysis    March 20, 2003   Volume 31, Issue 4 723-730 doi: 10.1016/s0731-7085(02)00687-8
Van Eenoo P, Delbeke FT, Roels K, Baert K.Non-steroidal anti-inflammatory drugs (NSAIDs) are prohibited by the International Federation of Horse Racing Authorities but are commonly used in veterinary practice. Plasma and urinary concentrations of the NSAID tolmetin were determined by a high-performance liquid chromatographic procedure with UV detection following oral administration of a dose of 1 g to six fasted untrained standard bred mares. With a limit of quantitation (LOQ) of 0.05 microg/ml tolmetin was present in plasma for 9-12 h post-administration. Maximum concentrations of 2.1+/-0.89 microg/ml were found after 0.7+/-0.25 h. T...
Flash electroretinography in standing horses using the DTL microfiber electrode.
Veterinary ophthalmology    March 19, 2003   Volume 6, Issue 1 27-33 doi: 10.1046/j.1463-5224.2003.00261.x
Komáromy AM, Andrew SE, Sapp HL, Brooks DE, Dawson WW.The goal of our study was the evaluation of a practical method for the recording of flash electroretinograms (ERGs) in sedated, standing horses with the DTL microfiber electrode. Methods: The horses were sedated intravenously with detomidine hydrochloride (0.015 mg/kg). The pupil was dilated and the auriculopalpebral nerve was blocked. The ERGs were recorded with the active electrode on the cornea (DTL), the reference electrode near the lateral canthus, and the ground electrode over the occipital bone. The light intensities of the white strobe light were 0.03 cd x s/m2 (scotopic) and 3 cd x s/...
Interactions of morphine and isoflurane in horses.
American journal of veterinary research    February 27, 2003   Volume 64, Issue 2 166-175 doi: 10.2460/ajvr.2003.64.166
Steffey EP, Eisele JH, Baggot JD.To quantitate dose- and time-related magnitudes of interactive effects of morphine (MOR) and isoflurane (ISO) in horses and to characterize pharmacokinetics of MOR in plasma and the ventilatory response to MOR during administration of ISO. Methods: 6 adult horses. Methods: Horses were anesthetized 3 times to determine the minimum alveolar concentration (MAC) of ISO in O2 and then to characterize the change in anesthetic requirement as defined by the alteration in ISO MAC following IV administration of saline (0.9% NaCl) solution and 2 doses of MOR (low dose, 0.25 mg/kg; high dose, 2.0 mg/kg). ...
Matrix-assisted laser-desorption time-of flight ionisation and high-performance liquid chromatography-electrospray ionisation mass spectral analyses of two glycosylated recombinant epoetins.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences    January 30, 2003   Volume 785, Issue 2 205-218 doi: 10.1016/s1570-0232(02)00824-3
Stanley SM, Poljak A.Mass spectrometric analyses of the recombinant proteins in Eprex and Aranesp were undertaken with the goal of producing reference mass spectra and evaluating strategies to improve its applicability as a method for equine and canine doping control of these substances. A simple, low chemical noise deglycosylation reaction removed microheterogeneity due to post-translational carbohydrate attachment and both proteins were detectable using MALDI-TOF-MS. Deglycosylated human erythropoietin (hEPO) was also detected using HPLC-ESI-MS. This is the first time that spectra of deglycosylated Eprex and Ara...
Antibody levels by indirect ELISA test in Trypanosoma evansi infected horses following treatment with quinapyramine sulphate.
Veterinary parasitology    January 14, 2003   Volume 111, Issue 1 59-63 doi: 10.1016/s0304-4017(02)00331-x
Monzon CM, Mancebo OA, Russo AM.An ELISA test was used to determine the persistence of antibody levels in horses following treatment for Trypanosoma evansi. In 17 horses with T. evansi from two farms treated and cured with quinapyramine sulphate, ELISA antibody levels fell progressively post-treatment, but remained with positive results for 22.6 months in one horse, 12.8 months in a second, 4.1 months in another four and 2.3 months in three, whilst the rest became negative at 2.3 months. In two horses that suffered a post-treatment infection relapse the decrease in ELISA levels was only temporary, and a new increase in antib...
Clinical pharmacokinetics of norfloxacin-glycine acetate after intravenous and intramuscular administration to horses.
Research in veterinary science    January 1, 2003   Volume 74, Issue 1 79-83 doi: 10.1016/s0034-5288(02)00150-9
Park SC, Yun HI.The pharmacokinetic properties of norfloxacin-glycine acetate (NFLXGA) were determined in six horses following a single intravenous (i.v.) and intramuscular (i.m.) dose of 4 mgkg(-1) body weight. Following i.v. and i.m. administration, the plasma drug concentrations were best fitted by an open two-compartment model with a rapid distribution phase. After i.v. NFLXGA administration, the distribution (t(1/2alpha)) and elimination half-life (t(1/2beta)) were 0.42 (0.05) and 5.44 (1.36)h. The volume of distribution of NFLXGA at steady state (Vd(ss)) was 2.19 (0.53) Lkg(-1). After NFLXGA i.m. admini...
In vitro effects of oxytocin, acepromazine, detomidine, xylazine, butorphanol, terbutaline, isoproterenol, and dantrolene on smooth and skeletal muscles of the equine esophagus.
American journal of veterinary research    December 21, 2002   Volume 63, Issue 12 1732-1737 doi: 10.2460/ajvr.2002.63.1732
Wooldridge AA, Eades SC, Hosgood GL, Moore RM.To characterize the in vitro effects of oxytocin, acepromazine, xylazine, butorphanol, detomidine, dantrolene, isoproterenol, and terbutaline on skeletal and smooth muscle from the equine esophagus. Methods: 14 adult horses without digestive tract disease. Methods: Circular and longitudinal strips from the skeletal and smooth muscle of the esophagus were suspended in tissue baths, connected to force-displacement transducers interfaced with a physiograph, and electrical field stimulation was applied. Cumulative concentration-response curves were generated for oxytocin, acepromazine, xylazine, d...
Detection of inhaled salbutamol in equine urine by ELISA and GC/MS2.
Biomedical chromatography : BMC    December 11, 2002   Volume 16, Issue 8 513-516 doi: 10.1002/bmc.194
Eenoo PV, Delbeke FT.Salbutamol is a beta-adrenergic agonist that is used in the treatment of asthma in humans and chronic obstructive pulmonary disease in horses. Because of its stimulating and growth promoting properties, it is prohibited by horse racing authorities. Recently a number of adapters (eg Equinehaler) have been designed, allowing the use of metered dose inhalers (MDI) approved for human use. However, information on detection times of salbutamol after administration of salbutamol in therapeutic doses by inhalation is lacking. In this study, 2 mg salbutamol (Ventolin) was administered to four standardb...
Comparison of serum and urinary concentrations of clenbuterol with and without concomitant administration of furosemide in horses.
Veterinary therapeutics : research in applied veterinary medicine    November 26, 2002   Volume 3, Issue 3 316-325 
Cohen ND, Hu Z, Stanley SD, Wang N.Furosemide is frequently used to control or prevent exercise-induced pulmonary hemorrhage in performance horses. The bronchodilating agent clenbuterol is also commonly used as a treatment for inflammatory airway disease in performance horses. Use of both medications is regulated by many racing authorities. The effects of concomitant administration of furosemide and clenbuterol on the pharmacokinetics of clenbuterol have not been well characterized. A study was designed to evaluate the influence of furosemide on serum and urine concentrations of clenbuterol after oral administration of clenbute...
Apparent ELISA detection times for albuterol after administration with the torpex equine inhaler device.
Veterinary therapeutics : research in applied veterinary medicine    November 26, 2002   Volume 3, Issue 3 297-307 
Dirikolu L, Mollett BA, Troppmann A, Woods WE, Bratton C, Cashman CP, Schroedter D, Mayer B, Lehner AF, Karpiesiuk W, Hughes C, Boyles J, Harkins JD....Single doses of one, three, and six actuations (120 micro g albuterol/actuation) and multiple daily doses (six actuations per dose four times daily) for 5 days of aerosol albuterol sulfate were sequentially administered to each of six horses using an equine inhaler device (Torpex, 3M Animal Care Products, St. Paul, MN [corrected] and Boehringer Ingleheim Vetmedica, Inc., St. Joseph, MO [corrected]). A 2-week washout period was allowed between each dose. ELISA testing revealed no evidence of albuterol in urine at 24 hours after any single-dose administration. Results indicated that 48 hours or ...
In vitro investigation of the effects of cyclooxygenase-2 inhibitors on contractile activity of the equine dorsal and ventral colon.
American journal of veterinary research    November 14, 2002   Volume 63, Issue 11 1496-1500 doi: 10.2460/ajvr.2002.63.1496
Van Hoogmoed LM, Snyder JR, Harmon FA.To evaluate the effect of 2 cyclooxygenase (COX)-2 inhibitors on contractile activity of the circular smooth muscle layer of the equine dorsal and ventral colon. Methods: Samples of the dorsal and ventral colon obtained from 10 healthy horses. Methods: Full-thickness tissue samples were collected from the dorsal colon in the area of the diaphragmatic flexure and the ventral colon in the area of the sternal flexure. Samples were cut into strips oriented along the fibers of the circular muscle layer and mounted in a tissue bath system for determination of contractile strength. Incremental amount...
Reduced resident time and pharmacodynamic effects of acepromazine after subclinical multiple dosage in exercised thoroughbreds.
Journal of veterinary pharmacology and therapeutics    November 9, 2002   Volume 25, Issue 5 379-382 doi: 10.1046/j.1365-2885.2002.00422.x
Chou CC, Chen CL, Rice BL, Colahan PT.No abstract available
Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares.
Journal of veterinary pharmacology and therapeutics    November 9, 2002   Volume 25, Issue 5 343-350 doi: 10.1046/j.1365-2885.2002.00434.x
Papich MG, Van Camp SD, Cole JA, Whitacre MD.Enrofloxacin was administered i.v. to five adult mares at a dose of 5 mg/kg. After administration, blood and endometrial biopsy samples were collected at regular intervals for 24 h. The plasma and tissue samples were analyzed for enrofloxacin and the metabolite ciprofloxacin by high-pressure liquid chromatography. In plasma, enrofloxacin had a terminal half-life (t(1/2)), volume of distribution (area method), and systemic clearance of 6.7 +/- 2.9 h, 1.9 +/- 0.4 L/kg, and 3.7 +/- 1.4 mL/kg/min, respectively. Ciprofloxacin had a maximum plasma concentration (Cmax) of 0.28 +/- 0.09 microg/mL. In ...
Anthelmintic resistance in nematodes of horses.
Veterinary research    October 22, 2002   Volume 33, Issue 5 491-507 doi: 10.1051/vetres:2002035
Kaplan RM.Suppressive anthelmintic treatment strategies originally designed to control Strongylus vulgaris in horses were extremely successful in reducing morbidity and mortality from parasitic disease. Unfortunately, this strategy has inadvertently resulted in the selection of drug-resistant cyathostomes (Cyathostominea), which are now considered the principal parasitic pathogens of horses. Resistance in the cyathostomes to benzimidazole drugs is highly prevalent throughout the world, and resistance to pyrantel appears to be increasingly common. However, there are still no reports of ivermectin resista...
Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training.
Journal of the American Veterinary Medical Association    October 22, 2002   Volume 221, Issue 8 1139-1143 doi: 10.2460/javma.2002.221.1139
Nieto JE, Spier S, Pipers FS, Stanley S, Aleman MR, Smith DC, Snyder JR.To compare effects of a commercially available omeprazole paste and a compounded omeprazole suspension on healing of gastric ulcers in Thoroughbred racehorses in active training. Methods: Randomized controlled trial. Methods: 32 horses with gastric ulcers. Methods: Horses were assigned to 2 groups on the basis of endoscopic gastric ulcer severity. Group-1 horses were treated with omeprazole suspension for 30 days and with omeprazole paste for an additional 30 days. Group-2 horses were treated with omeprazole paste for 30 days and omeprazole suspension for an additional 30 days. Serum omeprazol...
Fenbendazole pharmacokinetics, metabolism, and potentiation in horses.
Drug metabolism and disposition: the biological fate of chemicals    October 19, 2002   Volume 30, Issue 11 1230-1239 doi: 10.1124/dmd.30.11.1230
McKellar QA, Gokbulut C, Muzandu K, Benchaoui H.The present study was designed to describe the pharmacokinetics and fecal excretion of fenbendazole (FBZ) and fenbendazole sulphoxide (FBZSO) and their metabolites in horses, to investigate the effects which concurrent feeding has on the absorption and pharmacokinetics of FBZ, and to determine the effect of coadministration of the metabolic inhibitor piperonyl-butoxide on the in vivo pharmacokinetics and in vitro liver microsomal metabolism of sulfide and sulfoxide benzimidazoles. The effect of piperonyl-butoxide on the enantiomeric genesis of the sulfoxide moiety was also investigated. Follow...
Detection of inhaled clenbuterol in horse urine by GC/MS2.
Biomedical chromatography : BMC    October 16, 2002   Volume 16, Issue 7 475-481 doi: 10.1002/bmc.188
Van Eenoo P, Delbeke FT, Deprez P.Clenbuterol, a beta-adrenergic agonist, is used in the treatment of recurrent airway obstruction in horses. It is prohibited by horse racing authorities, because of its stimulating and growth-promoting properties. However, information on detection times of clenbuterol after administration by nebulization is lacking. In this study, a fast, sensitive quantitative GC-MS(2) method for the detection of clenbuterol in urine was developed. Alkaline liquid-liquid extraction was followed by derivatization to a cyclic methyl boronate derivative and analysis on a Finnigan MAT GCQ instrument. Method valid...
Pharmacokinetics of cephalexin in the horse after intravenous and intramuscular administration of two formulations.
Veterinary journal (London, England : 1997)    October 3, 2002   Volume 164, Issue 1 74-76 doi: 10.1053/tvjl.2001.0666
Villa R, Belloli C, Cagnardi P, Sonzogni O, Bacchetta S, Carli S.No abstract available
Regulation of equine lymphocyte beta-adrenoceptors under the influence of clenbuterol and dexamethasone.
Equine veterinary journal    October 3, 2002   Volume 34, Issue 6 587-593 doi: 10.2746/042516402776180115
Abraham G, Brodde OE, Ungemach FR.In 12 healthy horses, the effects of the beta2-agonist clenbuterol and the glucocorticoid dexamethasone on the lymphocyte beta2-adrenoceptor density and affinity (determined by (-)-[125I]-iodocyanopindolol binding) as well as its responsiveness (assessed by lymphocyte cyclic AMP [cAMP] responses to 10 micromol/l (-)-isoprenaline) were studied. Clenbuterol treatment, 2 x 0.8 microg/kg/day i.v. for 12 days, decreased significantly ICYP binding sites by approximately 30-40%; concomitantly, lymphocyte cAMP response to (-)-isoprenaline was reduced. After withdrawal of clenbuterol, beta2-adrenocepto...
Pharmacokinetics of gentamicin C1, C1a and C2 in horses after single intravenous dose.
Equine veterinary journal    October 3, 2002   Volume 34, Issue 6 615-618 doi: 10.2746/042516402776180160
Steinman A, Isoherranen N, Ashoach O, Soback S.Gentamicin pharmacokinetics has not been studied in horses. Pharmacokinetics of gentamicin C1, C1a and C2 components following i.v. administration of total gentamicin at 6.6 mg/kg bwt to 6 healthy mature horses was determined. Significant differences in clearance, half-life (t 1/2), and mean residence time (MRT) between the gentamicin Cia and the 2 other components were found. The total body clearance (CL) of gentamicin C1a was 1.62 +/- 0.50 ml/min x kg and similar to the glomerular filtration rate (GFR) reported for horses. The CL of gentamicin C1 and C2 were 1.03 +/- 0.08 ml/min x kg and 1.1...
1 52 53 54 55 56 95